Connection

Search Results to Elaine M. Hylek, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Hylek, Elaine

PropertyValue
Research Expertise & Professional Interests Expertise includes: Arterial Thrombosis; Venous Thrombosis; Atrial Fibrillation; Safety and Effectiveness of Antithrombotic Therapy.
Self-Described Keywords Atrial Fibrillation

One or more keywords matched the following items that are connected to Hylek, Elaine

Item TypeName
Academic Article Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.
Academic Article An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
Academic Article Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
Academic Article Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Academic Article Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
Academic Article Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Academic Article Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Academic Article Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Academic Article Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
Academic Article Antithrombotic therapy in atrial fibrillation.
Academic Article Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.
Academic Article Does preadmission anticoagulation therapy reduce stroke severity in patients with atrial fibrillation?
Academic Article Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.
Academic Article Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.
Academic Article A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.
Academic Article A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.
Academic Article Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Academic Article The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation.
Academic Article Stroke prevention in elderly patients with atrial fibrillation.
Academic Article Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.
Academic Article Death and disability from warfarin-associated intracranial and extracranial hemorrhages.
Academic Article Reducing the risk for stroke in patients who have atrial fibrillation.
Academic Article Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Academic Article Warfarin for atrial fibrillation in community-based practise.
Academic Article Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
Academic Article Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.
Academic Article Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician.
Academic Article Oral anticoagulant therapy for patients with atrial fibrillation--an update.
Academic Article The need for new oral anticoagulants in clinical practice.
Academic Article Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
Academic Article Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Academic Article Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.
Academic Article Anticoagulation for valvular heart disease in community-based practice.
Academic Article Epidemiology of subtherapeutic anticoagulation in the United States.
Academic Article Bleeding risk on warfarin among elderly patients with atrial fibrillation.
Academic Article New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
Academic Article Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification.
Academic Article Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
Academic Article Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care.
Academic Article Use of statins and recurrence of atrial fibrillation after catheter ablation or electrical cardioversion. A systematic review and meta-analysis.
Academic Article American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.
Academic Article The business case for quality improvement: oral anticoagulation for atrial fibrillation.
Academic Article Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Academic Article Apixaban versus warfarin in patients with atrial fibrillation.
Academic Article Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.
Academic Article Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.
Academic Article Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
Academic Article Stroke prevention in atrial fibrillation: current status and near-future directions.
Academic Article Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
Academic Article Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis.
Academic Article Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Academic Article Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Academic Article N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Academic Article Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Obesity begets atrial fibrillation: a contemporary summary.
Academic Article Anticoagulation therapy for atrial fibrillation.
Academic Article Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
Academic Article Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Academic Article Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Academic Article Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
Academic Article Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration.
Academic Article Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Academic Article Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Academic Article Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Academic Article Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.
Academic Article Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Academic Article Antiplatelet therapy in prevention of cardio- and venous thromboembolic events.
Academic Article High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Academic Article Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.
Academic Article Gaps in translation from trials to practice: non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation.
Academic Article D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.
Academic Article Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin.
Academic Article An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.
Academic Article National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation.
Academic Article Outcomes of anticoagulation therapy in patients with mental health conditions.
Academic Article Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.
Academic Article Warfarin interactions with antibiotics in the ambulatory care setting.
Academic Article Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012.
Academic Article Biomarkers in lone atrial fibrillation - an additional ''fine tuning'' of risk?
Academic Article Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Academic Article Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
Academic Article High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Academic Article Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
Academic Article Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Academic Article Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.
Academic Article Impaired platelet nitric oxide response in patients with new onset atrial fibrillation.
Academic Article Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
Academic Article Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu.
Academic Article Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry.
Academic Article Patients'' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
Academic Article Dabigatran and mechanical heart valves--not as easy as we hoped.
Academic Article Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms.
Academic Article Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Left atrial appendage closure for stroke prevention in atrial fibrillation: response to an unmet need with an unclear direction.
Academic Article Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Academic Article The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
Academic Article Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.
Academic Article Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Academic Article Letter to the Editor: Managing Dabigatran-Related Bleeding.
Academic Article Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
Academic Article Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
Academic Article Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration''s Approach for Its Product Labeling.
Academic Article Atrial fibrillation in women: treatment.
Academic Article The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
Academic Article Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
Academic Article Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Academic Article Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?
Academic Article Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
Academic Article The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
Academic Article Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Academic Article North American Thrombosis Forum, AF Action Initiative Consensus Document.
Academic Article Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy.
Academic Article Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
Academic Article Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF).
Academic Article Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Academic Article Paroxysmal atrial fibrillation and the hazards of under-treatment.
Academic Article Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report.
Academic Article Gender and tachycardia: independent modulation of platelet reactivity in patients with atrial fibrillation.
Academic Article Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.
Academic Article Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Academic Article Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
Academic Article Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
Academic Article Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
Academic Article Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
Academic Article Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
Academic Article Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
Academic Article 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Academic Article Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.
Academic Article Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Academic Article Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.
Academic Article Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry.
Academic Article 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.
Academic Article Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
Academic Article Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
Academic Article 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Academic Article 2017?HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.
Academic Article 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.
Academic Article A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.
Academic Article Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial.
Academic Article Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).
Academic Article Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.
Academic Article Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
Academic Article Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF Registry.
Academic Article Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Academic Article Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
Academic Article Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.
Academic Article Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Global public awareness about atrial fibrillation.
Academic Article Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
Academic Article Incremental prognostic value of renal function for stroke prediction in atrial fibrillation.
Academic Article Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
Academic Article Apixaban for End-Stage Kidney Disease.
Academic Article Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries.
Academic Article Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
Academic Article Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.
Academic Article Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial.
Academic Article The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.
Academic Article Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
Academic Article Stroke prevention in atrial fibrillation: Closing the gap.
Academic Article Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.
Academic Article Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry).
Academic Article Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies.
Academic Article Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.
Academic Article International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.
Academic Article Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.
Academic Article Oral Anticoagulants in Liver Disease: Not Child''s Play.
Academic Article Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
Academic Article 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.
Academic Article Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial.
Academic Article Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
Academic Article Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation.
Grant Effect of Statins and Modifiable Factors on Stroke Outcome in Atrial Fibrillation
Academic Article Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.
Academic Article Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial.
Academic Article Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Academic Article Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
Academic Article Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF).
Academic Article Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018.
Academic Article Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.
Academic Article The importance of adherence and persistence in the elderly atrial fibrillation patient.

Highlights
Search Criteria
  • Atrial Fibrillation